⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VERA News
Vera Therapeutics, Inc. Class A Common Stock
Form 8-K
sec.gov
VERA
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
globenewswire.com
VERA
Form 8-K
sec.gov
VERA
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VERA
Form 8-K
sec.gov
VERA
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
VERA
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
globenewswire.com
VERA
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VERA
Payer-to-Payer API Reality Gap Report Finds Most Exchanged Data Still Fails at the Point of Operational Use
accessnewswire.com
CHCO
VERA
D
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR